Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Maynard

Showing results (471-480 of 4,533) with videos related to

Pageof 454
Sort By:
Nursing Times|October 15, 2005
1948: when nursing changed forever. Interview by Adrian O'DowdPeter Ardern, Betty Maynard
Health Policy (Amsterdam, Netherlands)|February 7, 1994
The market reform of the New Zealand health care system searching for the Holy Grail in the AntipodesP Borren, A Maynard
Pharmacoeconomics|May 7, 1996
Is there scope for improving the cost-effective prescribing of nonsteroidal anti-inflammatory drugs?K Bloor, A Maynard
The International Journal of Health Planning and Management|October 1, 1995
Health care reform: informing difficult choicesA Maynard, K Bloor
Journal of Social Policy|June 10, 1980
Budget allocation in the National Health ServiceA Maynard, A Ludbrook
European Journal of Public Health|January 5, 2002
Translating evidence into practice. The case of influenza vaccinationD McDaid, A Maynard
Diabetes & Metabolism|September 8, 2001
[The late referral of diabetic patients with kidney insufficiency to nephrologists has a high human and financial cost: interdisciplinary communication is urgently needed]C Maynard, D Cordonnier
Health Policy (Amsterdam, Netherlands)|January 25, 2003
Evaluating health interventions: exploiting the potentialAlan Maynard, David McDaid
Hospital & Community Psychiatry|October 1, 1980
A socialization group for clients in a partial hospitalization programL Maynard, K Hogan
Journal of the Royal Society of Medicine|April 30, 2015
Regulation of the pharmaceutical industry: promoting health or protecting wealth?Alan Maynard, Karen Bloor
Pageof 454

Showing results (471-480 of 4,533) with videos related to

Sort By:
Pageof 454
Nursing Times|October 15, 2005
1948: when nursing changed forever. Interview by Adrian O'DowdPeter Ardern, Betty Maynard
Health Policy (Amsterdam, Netherlands)|February 7, 1994
The market reform of the New Zealand health care system searching for the Holy Grail in the AntipodesP Borren, A Maynard
Pharmacoeconomics|May 7, 1996
Is there scope for improving the cost-effective prescribing of nonsteroidal anti-inflammatory drugs?K Bloor, A Maynard
The International Journal of Health Planning and Management|October 1, 1995
Health care reform: informing difficult choicesA Maynard, K Bloor
Journal of Social Policy|June 10, 1980
Budget allocation in the National Health ServiceA Maynard, A Ludbrook
European Journal of Public Health|January 5, 2002
Translating evidence into practice. The case of influenza vaccinationD McDaid, A Maynard
Diabetes & Metabolism|September 8, 2001
[The late referral of diabetic patients with kidney insufficiency to nephrologists has a high human and financial cost: interdisciplinary communication is urgently needed]C Maynard, D Cordonnier
Health Policy (Amsterdam, Netherlands)|January 25, 2003
Evaluating health interventions: exploiting the potentialAlan Maynard, David McDaid
Hospital & Community Psychiatry|October 1, 1980
A socialization group for clients in a partial hospitalization programL Maynard, K Hogan
Journal of the Royal Society of Medicine|April 30, 2015
Regulation of the pharmaceutical industry: promoting health or protecting wealth?Alan Maynard, Karen Bloor
Pageof 454